<DOC>
	<DOCNO>NCT02351323</DOCNO>
	<brief_summary>Over past two decade , type 2 diabetes mellitus ( T2DM ) emerge relative obscurity become one serious complication obesity Hispanic obese population , especially among family history T2DM . Few therapy demonstrate long term efficacy combat obesity risk T2DM youth . Given emerge evidence glutamine leucine ( build block protein ) may affect energy partition thus diabetes risk , relationship glutamine diabetic risk evaluate one adult observational cohort study data leucine lacking , plan conduct clinical trial determine efficacy glutamine reduce insulin resistance , diabetes risk factor . The primary specific aim research plan conduct randomize , double-blind , placebo control , clinical trial test efficacy 6 month supplement glutamine reduce biomarkers insulin resistance weight gain among 56 obese Hispanic adolescent age 12-19 year BMI 95th percentile family history T2DM . At end grant period , obtain preliminary data plan pivotal clinical trial glutamine couple without lifestyle change .</brief_summary>
	<brief_title>Novel Type 2 Diabetes Mellitus Preventive Therapies</brief_title>
	<detailed_description>Because recruitment difficulty design modify several time April 2013 able increase recruitment . The following change make initial final study design : 1 . Study move Clinical Translational Science Institute ( CTSI ) clinical setting ( Nutrition Fitness Life Clinic ) 2 . Ages eligible expand 12-19 year old 12-19.9 year old 3 . Ethnicity/Race expand Hispanic include races/ethnicities 4 . Patients without past family history T2DM make eligible 5 . Study period shorten 6 month 12-14 week 6 . Number require visit reduce 5 visit 3 visit ( take place regularly schedule clinic appointment ) 7 . Open label still randomize 8 . Those Glutamine arm provide lifestyle change intervention 9 . Glycosylated hemoglobin ( A1C ) use instead fast Homeostatic Model Assessment-Insulin Resistance ( HOMA-IR ) 10 . Non-fasting blood draw rather fast blood draw institute</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>1 . BMI ( k/m2 ) &gt; = 95th percentile ; 2 . Weight 150 400 pound ; 3 . Language : English Spanish ( The PI speak English Spanish fluently ) . 1 . History T2DM ; 2 . Prior current drug treatmeant would effect diabetes risk 3 . Use prescription strength glucocorticoid within three month screen , 4 . History syndrome medical disorder associate significant obesity ; 5 . Serum creatinine &gt; 1.2 mg/dL ; 6 . Alanine transaminase ( ALT ) Aspartate aminotransferase ( AST ) &gt; 90 international unit ( IU ) /L ( = 3 X normal limit ) ; 7 . Total bilirubin &gt; 2.5 time upper limit normal ; 8 . History moderate extreme physical activity , past current pregnancy ; 9 .Use illegal/illicit drug ; 10 . Unable comply protocol ; 11 . Any serious disease determine clinician potential study risk patient . 12 . Have kidney liver disorder , condition result ammonia accumulation 13 . Take Lactulose 14 . Are allergic monosodium glutamate ( MSG ) , glutamine , Crystal Light 15 . Have manic episode ( mental illness ) 16 . Take medication prevent seizures 17 . Take glutamine , supplement glutamine , hypoglycemiants , anticonvulsivant , ADHD medication , antilipidemiants , thyroid hormone 18 . Participation weight loss program use weight loss medication within six month screen result 5 % weight loss</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>